NO20020929L - Nye interferon beta-lignende molekyler - Google Patents

Nye interferon beta-lignende molekyler

Info

Publication number
NO20020929L
NO20020929L NO20020929A NO20020929A NO20020929L NO 20020929 L NO20020929 L NO 20020929L NO 20020929 A NO20020929 A NO 20020929A NO 20020929 A NO20020929 A NO 20020929A NO 20020929 L NO20020929 L NO 20020929L
Authority
NO
Norway
Prior art keywords
molecules
interferon beta
novel interferon
novel
beta
Prior art date
Application number
NO20020929A
Other languages
English (en)
Other versions
NO20020929D0 (no
Inventor
Anders Hjelholt Pedersen
Hans Thalsgaard Schambye
Kim Vilbour Andersen
Claus Bornaes
Poul Baad Rasmussen
Original Assignee
Maxygen Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maxygen Aps filed Critical Maxygen Aps
Publication of NO20020929D0 publication Critical patent/NO20020929D0/no
Publication of NO20020929L publication Critical patent/NO20020929L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/565—IFN-beta
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/215—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
NO20020929A 1999-08-27 2002-02-26 Nye interferon beta-lignende molekyler NO20020929L (no)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
DKPA199901197 1999-08-27
US16078299P 1999-10-21 1999-10-21
DKPA199901691 1999-11-26
DKPA200000194 2000-02-07
DKPA200000363 2000-03-07
DKPA200000642 2000-04-14
PCT/DK2000/000471 WO2001015736A2 (en) 1999-08-27 2000-08-25 Interferon-beta conjugates

Publications (2)

Publication Number Publication Date
NO20020929D0 NO20020929D0 (no) 2002-02-26
NO20020929L true NO20020929L (no) 2002-04-25

Family

ID=27545189

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20020929A NO20020929L (no) 1999-08-27 2002-02-26 Nye interferon beta-lignende molekyler

Country Status (14)

Country Link
EP (1) EP1328295A2 (no)
JP (1) JP2003527090A (no)
KR (1) KR20020034181A (no)
CN (1) CN1501815A (no)
AU (1) AU6687000A (no)
BR (1) BR0013638A (no)
CA (1) CA2380760A1 (no)
CZ (1) CZ2002521A3 (no)
HU (1) HUP0302674A2 (no)
IL (1) IL147581A0 (no)
MX (1) MXPA02001969A (no)
NO (1) NO20020929L (no)
SK (1) SK2942002A3 (no)
WO (1) WO2001015736A2 (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1329082C (zh) 1998-10-16 2007-08-01 拜奥根Idec马萨诸塞公司 干扰素－β－1a的聚合物缀合物及其使用
TR200101087T2 (tr) 1998-10-16 2001-09-21 Biogen, Inc. İnterferon beta-füzyon proteinleri ve kullanımları
US7431921B2 (en) 2000-04-14 2008-10-07 Maxygen Aps Interferon beta-like molecules
US7144574B2 (en) 1999-08-27 2006-12-05 Maxygen Aps Interferon β variants and conjugates
AU2002212107A1 (en) * 2000-11-02 2002-05-15 Maxygen Aps New multimeric interferon beta polypeptides
YU48703A (sh) * 2001-02-27 2006-05-25 Maxygen Aps Novi interferonu beta-slični molekuli
AU2002254174A1 (en) * 2001-03-13 2002-09-24 Vical Incorporated Interferon-beta polynucleotide therapy for autoimmune and inflammatory diseases
KR100511749B1 (ko) * 2001-11-06 2005-09-02 선바이오(주) 변형된 인터페론-베타, 및 이의 화학적으로 변형된 배합체
KR100964411B1 (ko) 2002-01-18 2010-06-15 바이오겐 아이덱 엠에이 인코포레이티드 생물학적 활성 화합물과 컨쥬게이팅되는 잔기를 갖는 폴리알킬렌 글리콜
WO2004020468A2 (en) * 2002-08-28 2004-03-11 Maxygen Aps Interferon beta-like molecules for treatment of cancer
US9125880B2 (en) * 2002-12-26 2015-09-08 Mountain View Pharmaceuticals, Inc. Polymer conjugates of interferon-beta with enhanced biological potency
PL1666496T3 (pl) * 2003-08-25 2014-08-29 Toray Industries Kompozyt interferonu beta
EP1674113A1 (en) * 2004-12-22 2006-06-28 F. Hoffmann-La Roche Ag Conjugates of insulin-like growth factor-1 (IGF-1) and poly(ethylene glycol)
KR20090047452A (ko) * 2006-08-08 2009-05-12 노바티스 백신즈 앤드 다이아그노스틱스, 인크. 생물학적 활성이 증강된 재조합 인터페론-베타
US7625555B2 (en) 2007-06-18 2009-12-01 Novagen Holding Corporation Recombinant human interferon-like proteins
CL2008002399A1 (es) * 2007-08-16 2009-01-02 Pharmaessentia Corp Conjugado sustancialmente puro que posee una porcion polimerica, una porcion proteica (interferon alfa 2b) y un ligante alifatico de 1 a 10 atomos de carbono, util en el tratamiento de las hepatitis b o c.
CN104043112B (zh) * 2014-07-01 2016-03-30 哈药集团生物工程有限公司 一种含有重组人干扰素α-2b(假单胞菌)的软膏药物组合物
EP4282485A3 (en) 2014-11-06 2024-01-17 PharmaEssentia Corporation Dosage regimen for pegylated interferon
EP3454887B1 (en) * 2016-05-13 2021-01-20 Orionis Biosciences BV Targeted mutant interferon-beta and uses thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5206344A (en) * 1985-06-26 1993-04-27 Cetus Oncology Corporation Interleukin-2 muteins and polymer conjugation thereof
WO1987000056A1 (en) * 1985-06-26 1987-01-15 Cetus Corporation Solubilization of proteins for pharmaceutical compositions using polymer conjugation
US4917888A (en) * 1985-06-26 1990-04-17 Cetus Corporation Solubilization of immunotoxins for pharmaceutical compositions using polymer conjugation
US4904584A (en) * 1987-12-23 1990-02-27 Genetics Institute, Inc. Site-specific homogeneous modification of polypeptides
US5218092A (en) * 1988-09-29 1993-06-08 Kyowa Hakko Kogyo Co., Ltd. Modified granulocyte-colony stimulating factor polypeptide with added carbohydrate chains
IL113280A (en) * 1994-04-12 2004-12-15 Res Dev Foundation A preparation for the treatment of self-immunization diseases with the help of interferon of one type
US5738846A (en) * 1994-11-10 1998-04-14 Enzon, Inc. Interferon polymer conjugates and process for preparing the same
JP2001511162A (ja) * 1997-02-06 2001-08-07 ノボ ノルディスク アクティーゼルスカブ 付加され、そして／又は除去された付着基を有するポリペプチド−ポリマー結合体
DE69838552T2 (de) * 1997-07-14 2008-05-21 Bolder Biotechnology, Inc., Louisville Derivate des wachstumshormons und verwandte proteine
CN1329082C (zh) * 1998-10-16 2007-08-01 拜奥根Idec马萨诸塞公司 干扰素－β－1a的聚合物缀合物及其使用

Also Published As

Publication number Publication date
WO2001015736A3 (en) 2003-05-22
EP1328295A2 (en) 2003-07-23
JP2003527090A (ja) 2003-09-16
KR20020034181A (ko) 2002-05-08
AU6687000A (en) 2001-03-26
WO2001015736A2 (en) 2001-03-08
NO20020929D0 (no) 2002-02-26
CA2380760A1 (en) 2001-03-08
IL147581A0 (en) 2002-08-14
HUP0302674A2 (hu) 2003-11-28
MXPA02001969A (es) 2003-07-21
CZ2002521A3 (cs) 2002-05-15
CN1501815A (zh) 2004-06-02
BR0013638A (pt) 2002-05-14
SK2942002A3 (en) 2002-08-06

Similar Documents

Publication Publication Date Title
NO20020929L (no) Nye interferon beta-lignende molekyler
DK1240172T3 (da) Nye aminopropylphosphinsyrer
NO20014518D0 (no) Nye forbindelser
DK1202994T3 (da) Nye forbindelser
NO2010019I1 (no) 6-per-deoksy-6-per-(2-karboksyl)tio-y-cyklodextrin
NO20003967D0 (no) Farmasøytiske preparater
DE60044622D1 (de) Polymerisationsverfahren
NO20021436D0 (no) Nye forbindelser
NO20020810L (no) Nye fenylpiperaziner
NO20015383D0 (no) Nye forbindelser
DK1331972T3 (da) Farmaceutiske præparater
DE60017202D1 (de) Polymerisationsverfahren
NO20015374L (no) Nye forbindelser
NO995945D0 (no) Nye forbindelser
DE29901646U1 (de) Pfosten
DE29900980U1 (de) Formteil
FI991621A (fi) Lajittelulaitteisto
NO20014629D0 (no) Nye forbindelser
DE50014800D1 (de) Glasnudel
NO20016273D0 (no) Nye forbindelser
DE50003528D1 (de) Formkörper
DE29906945U1 (de) Rungenpalette
DE50000737D1 (de) Getriebemotor
DE50202618D1 (de) Getriebemotor
SE9902939D0 (sv) Pharmaceuticals

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application